Tech Advisor Match

Startup Tender Offers and Secondary Sales: What Tech Employees Need to Know

You joined a startup five years ago. The equity you received seemed like a lottery ticket — potentially life-changing, probably worth nothing. Now the company is raising a Series D at a $4B valuation and the CFO is announcing a "tender offer" in which current investors are buying employee shares at $18/share. Or maybe no tender offer is coming and you're wondering whether to sell through Forge or Hiive instead.

Either path — a company-sponsored tender offer or an employee-initiated secondary sale — puts real money on the table before an IPO. But they work differently, they're taxed differently, and the decision to participate can have consequences that reach years into the future.

The QSBS trap: Selling your startup stock before a 5-year holding period forfeits any QSBS exclusion on that stock — potentially costing you $1M+ in federal taxes when compared to holding through IPO. This is the most commonly overlooked consequence of early secondary sales.

Tender offer vs. secondary sale: the difference

These terms are often used interchangeably, but they're structurally different:

Tender offer (company-sponsored): The company or a specific investor (often a late-stage VC or growth equity fund) formally offers to purchase shares from employees at a fixed price, during a defined window (typically 30–60 days). The company usually facilitates the process through a platform like Carta, Fidelity, or its transfer agent. Employees choose how many eligible shares to sell, up to a cap set by the company (often 10–25% of vested holdings).

Secondary sale (employee-initiated): An employee approaches a secondary market platform (Forge Global, Hiive, EquityBee, Nasdaq Private Market) to find a buyer independently. The company is not the buyer — typically it's an accredited investor, hedge fund, or secondary fund. The company retains a Right of First Refusal (ROFR) in almost all cases, meaning it can match any proposed purchase price and buy the shares itself instead of allowing the sale to proceed to the third party.

Factor Tender offer Secondary sale
Who initiates Company or lead investor Employee
Price source Negotiated by company, fixed for all participants Market price, negotiated with buyer (often a discount to last round)
Company involvement High — company facilitates transfer ROFR exercise, board approval typically required
Sale cap Often 10–25% of vested shares Varies; company may restrict amounts or block entirely
Discounts to last round Usually priced at or near last round (common shares) Typically 20–40% discount to last round preferred price
Closing time 30–60 days, structured process Weeks to months; ROFR adds 30–45 days minimum

How tender offers work mechanically

When your company announces a tender offer, you'll typically receive a detailed "offer to purchase" document that spells out:

You must own shares, not just options, to participate. If you have unexercised ISOs or NSOs, you'll need to exercise them first to receive common stock — and that exercise itself has tax consequences. Tender offers rarely accept unexercised options directly.

Exercising options to participate

If you want to tender shares but only have unexercised stock options, your path is:

  1. Exercise the options (paying the strike price × number of shares)
  2. Receive common stock
  3. Tender that stock in the offer

For NSOs, the exercise spread (FMV at exercise minus strike) is immediately ordinary income, withheld by the company. Tendering the resulting shares at the offer price generates a short-term capital gain (if sold within a year of exercise) or long-term gain (if held 1+ year, though this rarely applies in a same-day exercise-and-tender).

For ISOs, the exercise spread is an AMT preference item (not regular income). If you immediately sell the stock in the tender offer in the same calendar year as exercise, the ISO disqualifies as a "disqualifying disposition" — the spread is ordinary income, no AMT exposure. This is actually favorable if your goal is simply to get liquidity: you avoid AMT complexity by intentionally disqualifying.

Secondary market mechanics

How secondary platforms work

Platforms like Forge Global, Hiive, EquityBee, and Nasdaq Private Market facilitate connections between employees with illiquid startup equity and accredited investors looking to buy pre-IPO positions. The process:

  1. Seller lists shares: You indicate how many shares you want to sell and at what price floor (or you let the platform find a price).
  2. Platform finds a buyer: Typically an institutional secondary fund or accredited investor. Platforms charge 3–5% of the transaction value.
  3. ROFR process: Your company's counsel (or transfer agent) receives formal notice of the proposed transaction. Under your stock agreement and the company's charter, the company has the right to match the terms and buy the shares itself instead of letting the sale proceed to the third party.
  4. If ROFR is not exercised: The board typically must approve the transfer. Transfer agent processes the paperwork. Timeline: 2–4 months total.

Right of First Refusal (ROFR)

Almost every startup charter includes a ROFR on employee shares. What this means practically:

Companies at earlier stages are more likely to block or exercise ROFR to maintain a clean cap table. Late-stage companies approaching IPO are more likely to have an established secondary policy and let transactions proceed.

Pricing: why you'll see a 20–40% discount

Secondary buyers price in several risks:

If the last round was at $20/share (preferred), expect secondary bids for your common shares at $12–16/share — roughly 20–40% lower. For a company with a large liquidation preference stack or a down-round history, the discount can be steeper.

The QSBS trap — read this before you sell

If your shares qualify as Qualified Small Business Stock (§ 1202), selling before the holding period requirement forfeits that exclusion permanently on the sold shares.

QSBS holding period under OBBBA

For stock acquired before July 4, 2025: you needed to hold 5+ years for 100% gain exclusion (up to $10M or 10× basis).1

For stock acquired after July 4, 2025: tiered exclusion kicks in — 50% at 3 years, 75% at 4 years, 100% at 5 years — with a cap of the greater of $15M or 10× adjusted basis per issuer.1

Example: You early-exercised ISOs at $0.10/share in 2022 with an 83(b) election. The company is now doing a tender offer at $20/share. If you've held the stock for 4+ years and it qualifies as QSBS (pre-July 4, 2025 stock), 100% of your gain up to $10M is federal-tax-free if you wait just one more year to hit 5 years. Selling now triggers capital gains on the entire gain. At a $1M gain, you're looking at $200K–$238K in federal tax that you'd avoid by waiting.

What qualifies as QSBS

The basic tests — all must be met at time of stock issuance:

§ 1045 rollover: one way to preserve QSBS

If you need liquidity but want to preserve QSBS treatment, § 1045 allows you to roll the proceeds from a QSBS sale into a new QSBS investment within 60 days without triggering gain recognition. You transfer the holding period and gain deferral. This is complex and has specific requirements — but it's a legitimate path if you're sitting on a large pre-IPO gain and need to redeploy capital into another qualified startup rather than pay tax now. This requires careful coordination with a tax professional before executing.

Tax treatment summary by equity type

What you're selling Tax treatment Key traps
Common stock (early-exercised ISOs, 83(b) election) LTCG if held 1+ year. QSBS exclusion possible if held 5 years (or 3/4/5 tiered for post-OBBBA stock) Selling before QSBS threshold; CA does not conform to QSBS
Unexercised ISOs — exercise + same-year tender Disqualifying disposition: exercise spread + gain is ordinary income Could be worse than AMT if spread is small vs gain
Unexercised ISOs — exercise + hold 1 year, then sell Exercise spread = AMT preference item; gain above FMV-at-exercise = LTCG AMT cash exposure at exercise if can't sell yet; pre-IPO secondary allows same-year sale, converting to disqualifying
NSOs — exercise + tender Exercise spread = ordinary income (W-2); any gain above FMV at exercise = STCG or LTCG based on holding period 22% supplemental withholding may be less than actual rate; watch for underpayment
RSUs (post-vest shares) Vest-day FMV already taxed as ordinary income; secondary sale creates STCG/LTCG on appreciation since vest RSUs are not QSBS-eligible; most pre-IPO companies don't grant RSUs (double-trigger RSUs are a late-stage construct)

Evaluating a tender offer: should you participate?

The financial calculus depends on your personal situation, but here's the framework:

Step 1: What's your actual after-tax proceeds?

The offer price is not what you receive. Model it out:

A $20/share tender price, with $18/share gain, can yield $11–14/share after-tax depending on your state and holding period.

Step 2: What's your exit expectation without selling?

Think through three scenarios:

This is fundamentally a question about your estimate of the company's exit probability and exit multiple — and your personal tolerance for concentrated, illiquid risk.

Step 3: What does this money mean to you today?

This is the dimension that pure IRR math misses. If selling 15% of your shares funds a house down payment, eliminates high-interest debt, or reduces concentration risk that is causing real stress — that's worth something. Personal finance is personal. Liquidity has real option value.

The 25% rule of thumb: Many tech employees and financial advisors use a rough heuristic: taking partial liquidity (up to ~25% of vested holdings) in a company-sponsored tender offer is reasonable diversification, especially for employees 5+ years into their equity journey. It's not "selling your winner early" — it's acknowledging that you have one stock representing a large share of your net worth, and that concentration risk has a real cost.

The QSBS deadline override

If you're within 6–12 months of a 5-year QSBS holding date, and the gain would be excluded federally (potentially a $10M–$15M tax-free event), the math almost always says: wait. The forgone QSBS benefit typically exceeds any benefits of liquidity unless your personal financial need is severe or you have strong reason to believe the company's value will decline before an exit.

What to check before participating

  1. Read your stock agreement and the offer letter in full. Look for transfer restrictions, clawback provisions, and any representations you're being asked to make.
  2. Verify your equity type. Common shares, ISOs, NSOs, and RSUs are treated differently. Know what you hold before making any election.
  3. Calculate your QSBS holding period. When did you receive and pay for the shares? If you early-exercised ISOs with an 83(b), your clock started then. If you exercised post-vesting, it started at exercise.
  4. Check your company's 409A valuation. The 409A represents the IRS-acceptable FMV of common shares. If the tender offer price is above the 409A, exercise is at a tax loss — but you may owe more income tax on the gain than you expect. If below, something unusual is happening.
  5. Understand any lockup or hold requirements after the tender. Some tender offers require employees who sell to sign side agreements about future behavior.
  6. Talk to a tax professional before the deadline. Tender offers are time-bound. You don't want to be making a tax-sensitive decision — that may affect six or seven figures — without a professional review of your specific numbers.

When does a secondary sale make sense (without a tender offer)?

Without a company-sponsored tender offer, secondary sales are harder to execute, slower, and more expensive (platform fees + steep discounts). They generally make sense when:

Secondary sales are generally not worth pursuing speculatively to "lock in" a high valuation. The discount to last-round price, taxes, fees, and ROFR delay make this an expensive form of liquidity. Tender offers — where the company sets a fair price, handles the process, and often covers transfer fees — are the more favorable mechanism.

When to work with a financial advisor

Most tender offer decisions can be evaluated using the framework above. But the following situations benefit significantly from professional guidance:

A fee-only financial advisor who works with tech employees can model your specific equity stack, run your QSBS eligibility analysis, and give you a clear after-tax comparison across your options.

Get help before the tender offer deadline

Tender offers are time-limited decisions with permanent tax consequences. A fee-only advisor who works with startup employees can run your specific QSBS analysis, model the after-tax comparison, and tell you whether to participate — before the deadline closes.

Sources

  1. One Big Beautiful Bill Act (OBBBA, July 2025) — QSBS changes: $15M exclusion cap, 50/75/100% tiered exclusion at 3/4/5 years for post-July 4, 2025 stock, $75M asset threshold at issuance. Nelson Mullins analysis: nelsonmullins.com; IRC § 1202 as amended.
  2. IRS Rev. Proc. 2025-32 — 2026 LTCG thresholds ($49,450/$98,900 zero-rate; $566,700/$613,700 top-rate for single/MFJ); NIIT threshold at $200K/$250K MAGI per IRC § 1411. irs.gov/pub/irs-drop/rp-25-32.pdf
  3. IRS Publication 550 — Investment Income and Expenses, covering stock option disqualifying dispositions, AMT preference items for ISOs, and QSBS exclusion overview. irs.gov/publications/p550
  4. SEC — Rule 13e-4, regulating tender offers by issuers, including disclosure requirements and timing rules. sec.gov; Investor Bulletin on tender offers: investor.gov

Tax values verified as of June 2026. QSBS rules reflect OBBBA enactment (July 2025). LTCG thresholds per IRS Rev. Proc. 2025-32. Consult a tax professional for advice specific to your situation.